OPEN END TURBO LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 02:29:19 26/06/2024 pm IST | ||
| 0.61 EUR / 0.62 EUR | +6.03% |
|
| Current month | +16.00% | ||
| 1 month | +16.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.58 | -7.94% |
| 24/24/24 | 0.63 | +10.53% |
| 21/24/21 | 0.57 | +1.79% |
| 20/24/20 | 0.56 | +33.33% |
| 19/24/19 | 0.42 | -12.50% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 12:22 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MB741L |
| ISIN | DE000MB741L0 |
| Date issued | 07/06/2023 |
| Strike | 43.62 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.01 € |
|---|---|
| Lowest since issue | 0.101 € |
| Spread | 0.01 € |
| Spread % | 1.61% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.4
EUR
Average target price
52.64
EUR
Spread / Average Target
+6.56%
- Stock Market
- Certificates
- Certificat
